Meningiomas and meningeal tumors

Oncology of CNS Tumors

Volumn , Issue , 2010, Pages 95-118

  Westphal, Manfred ^a   Lamszus, Katrin ^a   Tonn, Jörg Christian ^b  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84872678140     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-3-642-02874-8_4     Document Type: Chapter

References (65)

1. Alen JF, Lobato RD, Gomez PA, Boto GR, Lagares A, Ramos A, Ricoy JR. (2001) Intracranial hemangiopericytoma: study of 12 cases. Acta Neurochir (Wien) 143:575-586
2. Al-Mefti O. (1991) Meningiomas. Raven, New York
3. Al-Mefti O. (1998) Operative atlas of meningioma. Lippincott-Raven, Philadelphia, PA
4. Becker G, Jeremic B, Pitz S, Buchgeister M, Wilhelm H, Schiefer U, Paulsen F, Zrenner E, Bamberg M. (2002) Stereotactic fractionated radiotherapy in patients with optic nerve sheath meningioma. Int J Radiat Oncol Biol Phys 54:1422-1429
5. Bendszus M, Rao G, Burger R, Schaller C, Scheinemann K, Warmuth-Metz M, Hofmann E, Schramm J, Roosen K, Solymosi L. (2000) Is there a benefit of preoperative menin-gioma embolization? Neurosurgery 47:1306-1311; discussion 1311-1302
6. Beriwal S, Hou JS, Miyamoto C, Garcia-Young JA. (2003) Primary dural low grade BCL-2 negative follicular lym-phoma: a case report. J Neurooncol 61:23-25
7. Buhl R, Hugo HH, Mehdorn HM. (2001) Brain oedema in secretory meningiomas. J Clin Neurosci 8(Suppl 1):19-21
8. Bull WJ, Vandevender D, Cimino VG. (2003) Reconstruction of defects of the cranial base. Tech Neurosurg 9:106-112
9. Carroll RS, Schrell UM, Zhang J, Dashner K, Nomikos P, Fahlbusch R, Black PM. (1996) Dopamine D1, dopamine D2, and prolactin receptor messenger ribonucleic acid expression by the polymerase chain reaction in human men-ingiomas. Neurosurgery 38:367-375
10. Chamberlain MC. (2004) Meningiomas. Curr Treat Options Neurol 3:67-76
11. Chamberlain MC, Tsao-Wei DD, Groshen S. Temozolomide for treatment-resistant recurrent meningioma. Neurology 62:1210-1212
12. Christensen HC, Kosteljanetz M, Johansen C. (2003) Incidences of gliomas and meningiomas in Denmark, 1943 to 1997. Neurosurgery 52:1327-1333; discussion 1333-1324
13. Claus EB, Black PM, Bondy ML, Calvocoressi L, Schildkraut JM, Wiemels JL, Wrensch M. (2007) Exogenous hormone use and meningioma risk: what do we tell our patients? Cancer 110:471-476
14. Collins VP. (2004) Brain tumours: classification and genes. J Neurol Neurosurg Psychiatry 75(Suppl 2):ii2-11
15. Couldwell WT, Cole CD, Al-Mefty O. (2007) Patterns of skull base meningioma progression after failed radiosurgery. J Neurosurg 106:30-35
16. Ecker RD, Marsh WR, Pollock BE, Kurtkaya-Yapicier O, McClelland R, Scheithauer BW, Buckner JC. (2003) Hemangiopericytoma in the central nervous system: treatment, pathological features, and long-term follow-up in 38 patients. J Neurosurg 98:1182-1187
17. Egan RA, Lessell S. (2002) A contribution to the natural history of optic nerve sheath meningiomas. Arch Ophthalmol 120:1505-1508
18. Fountas KN, Kapsalaki EZ, Gotsis SD, Kapsalakis JZ, Smisson HF, 3rd, Johnston KW, Robinson JS, Jr., Papadakis N. (2000) In vivo proton magnetic resonance spectroscopy of brain tumors. Stereotact Funct Neurosurg 74:83-94
19. Goetz P, Lafuente J, Revesz T, Galloway M, Dogan A, Kitchen N. (2002) Primary low-grade B-cell lymphoma of mucosa-associated lymphoid tissue of the dura mimicking the presentation of an acute subdural hematoma. Case report and review of the literature. J Neurosurg 96:611-614
20. Grunberg SM. (1994) Role of antiprogestational therapy for meningiomas. Hum Reprod 9(Suppl 1):202-207
21. Han JH, Kim DG, Chung HT, Park CK, Paek SH, Kim CY, Jung HW. (2008) Gamma knife radiosurgery for skull base meningiomas: long-term radiologic and clinical outcome. Int J Radiat Oncol Biol Phys 72(5):1324-1332
22. Hart DJ, Gianotta SL. (2003) Complex cranial base menin-gioma: combined management. Tech Neurosurg 9:86-92
23. Hsu DW, Efird JT, Hedley-Whyte ET. (1997) Progesterone and estrogen receptors in meningiomas: prognostic considerations. J Neurosurg 86:113-120
24. Jääskeläinen J, Louis DN, Paulus W, Haltia M. (2000) Haemangiopericytoma. In: Kleihues P, Cavanee WK (eds) Tumors of the central nervous system: pathology and genetics. IARC Press, Lyon
25. Jhawar BS, Fuchs CS, Colditz GA, Stampfer MJ. (2003) Sex steroid hormone exposures and risk for meningioma. J Neurosurg 99:848-853
26. Johnson MD, Kinney MC, Scheithauer BW, Briley RJ, Hamilton K, McPherson WF, Barton JH, Jr. (2000) Primary intracerebral Hodgkin's disease mimicking meningioma: case report. Neurosurgery 47:454-456; discussion 456-457
27. Kaminski JM, Movsas B, King E, Yang C, Kronz JD, Alli PM, Williams J, Brem H. (2001) Metastatic meningioma to the lung with multiple pleural metastases. Am J Clin Oncol 24:579-582
28. Kleinschmidt-DeMasters BK. (2001) Dural metastases. A retrospective surgical and autopsy series. Arch Pathol Lab Med 125:880-887
29. Kondziolka D, Nathoo N, Flickinger JC, Niranjan A, Maitz AH, Lunsford LD. (2003) Long-term results after radiosur-gery for benign intracranial tumors. Neurosurgery 53:815-821; discussion 821-812
30. Kremer S, Grand S, Remy C, Pasquier B, Benabid AL, Bracard S, Le Bas JF. (2004) Contribution of dynamic contrast MR imaging to the differentiation between dural metastasis and meningioma. Neuroradiology 46:642-648
31. Kyritsis AP. (1996) Chemotherapy for meningiomas. J Neurooncol 29:269-272
32. Laidlaw JD, Kumar A, Chan A. (2004) Dural metastases mimicking meningioma. Case report and review of the literature. J Clin Neurosci 11:780-783
33. Lamszus K. (2004) Meningioma pathology, genetics, and biology. J Neuropathol Exp Neurol 63:275-286
34. Lamszus K, Kluwe L, Matschke J, Meissner H, Laas R, Westphal M. (1999) Allelic losses at 1p, 9q, 10q, 14q, and 22q in the progression of aggressive meningiomas and undif-ferentiated meningeal sarcomas. Cancer Genet Cytogenet 110:103-110
35. Lamszus K, Lengler U, Schmidt NO, Stavrou D, Ergun S, Westphal M. (2000) Vascular endothelial growth factor, hepatocyte growth factor/scatter factor, basic fibroblast growth factor, and placenta growth factor in human menin-giomas and their relation to angiogenesis and malignancy. Neurosurgery 46:938-947; discussion 947-938
36. Lamszus K, Vahldiek F, Mautner VF, Schichor C, Tonn J, Stavrou D, Fillbrandt R, Westphal M, Kluwe L. (2000) Allelic losses in neurofibromatosis 2-associated menin-giomas. J Neuropathol Exp Neurol 59:504-512
37. Longstreth WT, Jr., Phillips LE, Drangsholt M, Koepsell TD, Custer BS, Gehrels JA, van Belle G. (2004) Dental X-rays and the risk of intracranial meningioma: a population-based case-control study. Cancer 100:1026-1034
38. Loven D, Hardoff R, Sever ZB, Steinmetz AP, Gornish M, Rappaport ZH, Fenig E, Ram Z, Sulkes A. (2004) Non-resectable slow-growing meningiomas treated by hydroxyu-rea. J Neurooncol 67:221-226
39. Marc JA, Takei Y, Schechter MM, Hoffman JC. (1975) Intracranial hemangiopericytomas. Angiography, pathology and differential diagnosis. Am J Roentgenol Radium Ther Nucl Med 125:823-832
40. Mason WP, Gentili F, Macdonald DR, Hariharan S, Cruz CR, Abrey LE. (2002) Stabilization of disease progression by hydroxyurea in patients with recurrent or unresectable meningioma. J Neurosurg 97:341-346
41. Muracciole X, Regis J. (2008) Radiosurgery and carcino-genesis risk. Prog Neurol Surg 21:207-213
42. Newman SA. (2003) Optic nerve sheath meningiomas. Tech Neurosurg 9:64-77
43. Norden AD, Drappatz J, Wen PY. (2007) Targeted drug therapy for meningiomas. Neurosurg Focus 23:E12
44. Perry A, Dehner LP. (2003) Meningeal tumors of childhood and infancy. An update and literature review. Brain Pathol 13:386-408
45. Perry A, Louis DN, Scheithauer BW, Budka H, von Deimling A. (2007) Meningiomas. In: Louis DN, Ohgaki H, Wiestler OD, Cavanee WK (eds) WHO classification of tumors of the central nervous system. IARC Press, Lyon, pp. 164-172
46. Preston DL, Ron E, Yonehara S, Kobuke T, Fujii H, Kishikawa M, Tokunaga M, Tokuoka S, Mabuchi K. (2002) Tumors of the nervous system and pituitary gland associated with atomic bomb radiation exposure. J Natl Cancer Inst 94:1555-1563
47. Probst EN, Grzyska U, Westphal M, Zeumer H. (1999) Preoperative embolization of intracranial meningiomas with a fibrin glue preparation. AJNR Am J Neuroradiol 20:1695-1702
48. Rosen CL, Ammerman JM, Sekhar LN, Bank WO. (2002) Outcome analysis of preoperative embolization in cranial base surgery. Acta Neurochir (Wien) 144:1157-1164
49. Rottnek M, Strauchen J, Moore F, Morgello S. (2004) Primary dural mucosa-associated lymphoid tissue-type lymphoma: case report and review of the literature. J Neurooncol 68:19-23
50. Ruttledge MH, Sarrazin J, Rangaratnam S, Phelan CM, Twist E, Merel P, Delattre O, Thomas G, Nordenskjold M, Collins VP, et al (1994) Evidence for the complete inactiva-tion of the NF2 gene in the majority of sporadic menin-giomas. Nat Genet 6:180-184
51. Sadetzki S, Modan B, Chetrit A, Freedman L. (2000) An iatrogenic epidemic of benign meningioma. Am J Epidemiol 151:266-272
52. Sayagues JM, Tabernero MD, Maillo A, Trelles O, Espinosa AB, Sarasquete ME, Merino M, Rasillo A, Vera JF, Santos-Briz A, de Alava E, Garcia-Macias MC, Orfao A. (2006) Microarray-based analysis of spinal versus intracranial men-ingiomas: different clinical, biological, and genetic characteristics associated with distinct patterns of gene expression. J Neuropathol Exp Neurol 65:445-454
53. Simpson D. (1957) The recurrence of intracranial menin-giomas after surgical treatment. J Neurol Neurosurg Psychiatry 20:22-29
54. Sindou M. (2001) Meningiomas invading the sagittal or transverse sinuses, resection with venous reconstruction. J Clin Neurosci 8(Suppl 1):8-11
55. Sindou MP, Alvernia JE. (2006) Results of attempted radical tumor removal and venous repair in 100 consecutive menin-giomas involving the major dural sinuses. J Neurosurg 105: 514-525
56. Soyuer S, Chang EL, Selek U, McCutcheon IE, Maor MH. (2004) Intracranial meningeal hemangiopericytoma: the role of radiotherapy: report of 29 cases and review of the literature. Cancer 100:1491-1497
57. Strojan P, Popovic M, Jereb B. (2000) Secondary intracra-nial meningiomas after high-dose cranial irradiation: report of five cases and review of the literature. Int J Radiat Oncol Biol Phys 48:65-73
58. Swensen R, Kirsch W. (2002) Brain neoplasms in women: a review. Clin Obstet Gynecol 45:904-927
59. Tagle P, Villanueva P, Torrealba G, Huete I. (2002) Intracranial metastasis or meningioma? An uncommon clinical diagnostic dilemma. Surg Neurol 58:241-245
60. Tonn JC, Ott MM, Bouterfa Hikerkans S, Kapp M. (1997) Inverse correlation of cell proliferation and expression of progesterone receptors. Neuosurgery 41:1152-1159
61. Vuorinen V, Sallinen P, Haapasalo H, Visakorpi T, Kallio M, Jaaskelainen J. (1996) Outcome of 31 intracranial haeman-giopericytomas: poor predictive value of cell proliferation indices. Acta Neurochir (Wien) 138:1399-1408
62. Wan WL, Geller JL, Feldon SE, Sadun AA. (1990) Visual loss caused by rapidly progressive intracranial meningiomas during pregnancy. Ophthalmology 97:18-21
63. Weber RG, Bostrom J, Wolter M, Baudis M, Collins VP, Reifenberger G, Lichter P. (1997) Analysis of genomic alterations in benign, atypical, and anaplastic meningiomas: toward a genetic model of meningioma progression. Proc Natl Acad Sci USA 94:14719-14724
64. Westphal M, Heese O, de Wit M. (2003) Intracranial metastases: therapeutic options. Ann Oncol 14(Suppl 3): iii4-10
65. Zang KD. (2001) Meningioma, a cytogenetic model of a complex benign human tumor. Cytogenet Cell Genet 93: 207-220